Cancer by state and territory data visualisation
For many different cancers, this data visualisation provides cancer incidence and mortality data for each state and territory. For this visualisation and for reporting consistency and comparability, mortality data is sourced from the Australian Cancer Database.
State and territory cancer registries report a wide range of cancer statistics. The number of cases reported by AIHW for a given cancer in each jurisdiction may differ from the number published for that cancer in jurisdictions’ own reports. The following are some reasons for this:
- The data set supplied to AIHW by each cancer registry comes from a snapshot of the registry’s database taken at a specific point in time. If the cancer registry used a different snapshot as the basis of its jurisdictional report, then the number of cases reported by AIHW may differ from the number reported by the jurisdiction.
- The method used to aggregate data for reporting may differ slightly between different cancer registries. That is, the way the ICD-O-3 topography and morphology codes are mapped to ICD-10 codes might differ slightly. To ensure national consistency, the AIHW applies a single method to all jurisdictions’ data to ensure that the cancer groups are defined in the same way for all jurisdictions.
- Occasionally, based on the consensus of cancer experts, the World Health Organization redefines the so-called “behaviour” of a neoplasm. This means that a neoplasm that used to be defined as cancer is redefined as non-cancer or vice versa. There are two ways that such a change can be dealt with in cancer reporting, and different cancer registries might make different choices. One way is to report all neoplasms that were defined as cancer at the time the data were collected. The other way is to only report neoplasms that are currently defined as cancer. For example, if a neoplasm was defined as cancer up to and including 2017 but was redefined as non-cancer from 2018 onwards, the first method of reporting would count that neoplasm as cancer up to and including 2017 but not from 2018 onwards whereas the second method would not count that neoplasm as cancer in any year. The AIHW uses the second method whereas some jurisdictions might use the first.
Help with terms, and information about the data, is available by placing the mouse pointer over the icons found near the top of the page.
State and territory cancer incidence and mortality data visualisation
This cancer incidence by state and territory visualisation contains two figures. The visualisation presents statistics for the selected cancer and provides statistics by sex..
Figure 1 is a column graph that contains information on the number of cases diagnosed and the age-standardised rates of diagnosis from the selected cancer by sex for each state and territory and Australia for a selected year from 1982 to the most recent year available for reporting at the time of release.
Figure 2 is a line graph that contains information the number of cases diagnosed and the age-standardised rates of diagnosis from the selected cancer for a selected sex and state or territory from 1982 to the most recent year available for reporting at the time of release.
The visualisation includes information about many different cancers and the statistics within this visualisation are available in Excel format within the Data section of this report.
State and territory cancer incidence and mortality data are available as supplementary tables.
AIHW (Australian Institute of Health and Welfare) 2019. BreastScreen Australia monitoring report 2018. Cancer series no.127. Cat no. CAN 128. Canberra: AIHW
Al-Marhoon M, Osman A, Kamal M and Shokier A 2011. Incidental vs symptomatic renal tumours: Survival outcomes. Arab Journal of Urology 9(1): 17–21.
Luke C, Tracey E, Stapleton A and Roder D 2010. Exploring contrary trends in bladder cancer incidence, mortality and survival: implications for cancer research and cancer control. Internal Medicine Journal 40:357–62.
Qaseem A, Usman N, Jayaraj J S, et al. (September 02, 2019) Cancer of Unknown Primary: A Review on Clinical Guidelines in the Development and Targeted Management of Patients with the Unknown Primary Site. Cureus 11(9): e5552. doi:10.7759/cureus.5552
Smith D Supramaniam R, Marshall V and Armstrong B 2008. Prostate cancer and prostate specific antigen testing in New South Wales. Medical Journal of Australia 189(6): 315–18.
Vaccarella S, Franceschi S, Bray F, Wild C, Plummer M and Dal Maso L 2016. The increase in thyroid cancer may be due to an increase in medical surveillance and the introduction of new diagnostic techniques, such as neck ultrasonography. The New England Journal of Medicine 375: 614–17.
Victorian Cancer Registry 2023. Cancer in Victoria, 2022. Cancer Council Victoria, accessed 29 July 2024.
Wyld D, Wan M, Moore J, Dunn N and Youl P 2019. Epidemiological trends of neuroendocrine tumours over three decades in Queensland, Australia. Cancer Epidemiology, Volume 63, 101598, ISSN 1877–7821.